newsfilter
← Latest News
Business Wire·

Acorda Therapeutics Makes December 2022 $6.2 Million Interest Payment on Secured Debt in Cash

Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that it made a cash interest payment of approximately $6.2 million due on December 1, 2022 under its Convertible Senior Secured Notes Indenture. Acorda may elect